Names | |
---|---|
Preferred IUPAC name
(2R,3S,6S,7R,8R)-3-(3-Formamido-2-hydroxybenzamido)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl 3-methylbutanoate | |
Other names
Fintrol
| |
Identifiers | |
| |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.162.279 |
MeSH | Antimycin+A |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C28H40N2O9 | |
Molar mass | 548.633 g·mol−1 |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards
|
Acute toxic |
GHS labelling: | |
Danger | |
H301, H311, H331 | |
P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P311, P312, P321, P322, P330, P361, P363, P403+P233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Antimycin A (more exactly Antimycin A1b) is a secondary metabolite produced by Streptomyces bacteria[1] and a member of a group of related compounds called antimycins. Antimycin A is classified as an extremely hazardous substance in the United States, as defined in Section 302 of the U.S. Emergency Planning and Community Right-to-Know Act (42 U.S.C. 11002), and is subject to strict reporting requirements by facilities which produce, store, or use it in significant quantities.[2]
{{cite journal}}
: Cite journal requires |journal=
(help)